Chinese biotechnology firms have lagged behind their competitors for years in the use of artificial intelligence technologies. But increasingly, regulatory reforms are making it easier and cheaper for pharmaceutical companies in China to harness a vast trove of data collected from Chinese... Read More
Seeking to topple long-standing obstacles to drug innovation in Japan, pharmaceutical industry leaders in the country have outlined a slate of steps they propose the government take to foster research and development of new products, trim regulations and approval times, and speed... Read More
Advances in the use of artificial intelligence (AI) are fueling significant improvements in the field of radiology in Singapore, South Korea, and Australia, a new study has found. Eight in ten radiologists surveyed by health data firm Royal Phillips this year... Read More
With cancer a leading cause of death in Japan, the market for pharmaceuticals to treat tumors is expected to grow by 5% by 2023, and to represent one fifth of the market for pharmaceuticals by 2026. The prediction is part of a... Read More
Attracted by Shanghai government policies designed to encourage the development of the pharmaceutical industry, Western drug manufacturers are setting up shop in China’s financial hub. The biopharmaceutical firms are partnering with Chinese industry leaders, taking advantage of a reservoir of talented biopharma... Read More
With cancer a leading cause of death in Korea, the government plans to harness the power of big data to tackle the disease by increasing information sharing among healthcare institutions to bolster diagnosis, treatment, and research. At a meeting of the Korea... Read More
Plans by China to create a free trade port in Hainan province, which have moved forward swiftly this year, bolster opportunities for the growth of the country’s pharmaceutical industry. They are also likely to lower prices on imports for Chinese consumers who... Read More
China, Korea, Taiwan, and Japan are rapidly becoming world leaders in cell and gene therapy research and innovation, fueled by significant public and private investment and streamlined regulations that are spurring breakthroughs in the field. All three countries have long been leaders... Read More
Stepping up its commitment to researching the potential of cells harvested from human embryos, China has announced plans to construct what it says will be the largest stem cell technology laboratory in Asia. China sees the development of stem cell and regenerative... Read More
This article was originally published on MedTech Intelligence. With patients and medical providers across Asia and around the world forced by the global pandemic to rely on online platforms more than ever before, the medical device industry is finding itself uniquely vulnerable... Read More